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EDITORIAL Open Access
Recommendations for the early diagnosis of
COPD: the AIMAR view
Bartolome R Celli1,2
Chronic obstructive pulmonary disease (COPD) has the
dubious distinction of being one of the few major causes
of death that continues to rise in the United States and
the world [1]. In that sense, its prevention, early diagno-
sis when clinically present, and finally its appropriate
treatment should constitute a priority item in today’s
health care agenda. In this sense, the recently published
AIMAR’s recommendation for the early diagnosis of
COPD constitutes a valuable contribution to this con-
certed effort [2]. Professor Nardini and colleagues are to
be commended for the comprehensive effort that has
made this publication possible.
Perhaps the title is a little misguided as it only
describes the document as a “recommendation for diag-
nosis”, when in reality the content is extremely compre-
hensive covering not just diagnostic issues of relevance,
but it also develops, in rich detail, primary and second-
ary prevention as well as treatment. Furthermore, it ex-
tends its recommendations to the often forgotten area of
end-of-life and palliative care so important in our ageing
population. Perhaps the title should have included the
fact that it recommends prevention and treatment as
well as diagnosis. In their modesty, the authors do not
pretend this to be an evidence based document, primar-
ily due to the fact that no evidence methodology was
used, but its recommendations are very much in line
with those existing in the international guidelines [3,4].
The document begins with a layout of the landscape.
It attempts to relate what is known about prevalence
and the burden of COPD around the world to the situ-
ation in Italy itself. Overall, it would appear that there is
room to improve and in a more precise manner deter-
mine the Italian situation. It follows with a section on
prevention and then with an excellent discussion on the
issue of secondary screening. For this, the authors seem
to favor the use of a questionnaire to select individuals
likely to yield a favorable ratio of persons screened over
individuals who will ultimately have the disease. The sec-
tion on primary prevention not only concentrates on
smoking prevention, but importantly in education and
indoor and outdoor pollution. In this regard, it is im-
portant to remember that close to 20% of subjects
known to have limitation to airflow in population sur-
veys and who would qualify for a diagnosis of COPD, do
not have a history of smoking or even underlying
asthma [5-7]. Once again, the document emphasizes the
importance of the use of spirometry in an attempt to de-
crease not only the problem of under-diagnosis, but the
equally important and prevalent problem of misdiag-
nosis and miss treatment. In a series of figures and algo-
rithmic graphs, the reader is instructed on the sequential
approach to the suspected case and flow diagrams that
can help orient one’s practice to achieve the best pos-
sible yield.
Perhaps one of the novelties in relation to many other
documents is that the current recommendations address
the potential complementary role of primary care health
givers or GP’s and the specialist. It is clear to most, that
given the large volume of people who smoke and who
are potential candidates to develop COPD, it would be
impossible to care for all patients at the specialist level.
Therefore, a need exists to lay bridges that allow all
caregivers to play an important role in the containment
of the epidemic of COPD. Without being restrictive, this
document does an excellent job in addressing this issue.
Another area that is novel, is the integration of the
clinical impression to the spirometric results obtained
during the forced vital capacity maneuver. Indeed, the
controversy regarding whether to define COPD using a
strict value of the fixed ratio or to use the predicted
equations available to determine normalcy is left to the
criteria of the clinician facing the patient. In this regard,
I very much like the option presented, where the clin-
ician takes into account not just the spirometric result,
but incorporates his/her clinical acumen to make a
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definitive diagnosis. The document then addresses the
grading of disease severity. This is done incorporating
the current thinking that COPD is not just a disease of
the lungs, but also one that affects extra-pulmonary
organ systems and thus expands the possibility of using
multiple domains to the well-known physiological grad-
ing that has been so useful in the past. Following the de-
termination of the severity, the reader is led to the
logical question of how is the follow up going to be im-
plemented. In a table developed to synthesize the infor-
mation, the authors present their opinion on how to
achieve the goal while incorporating not only the spiro-
metric values, but also the oximetry results, a test that
has gradually become a vital sign in most offices.
Whether to refer to a specialist, if the patients is being
treated by a generalist, or whether the care is to remain
in the hands of the primary care environment is recom-
mended based on the severity and compromise of the
individual patient.
The recommendations follow with a very good review
of the elements needed to help a patient quit smoking if
he or she still does and then enters into the use of the
many medications now available to treat COPD. The al-
gorithm presented as Figure number 8 is, in my opinion,
very good. Not only does it provide the caregiver some
leeway on the therapy to indicate and at what level, but
it is also simple and direct. Most guidelines now present
complex schemes that are difficult to follow and even
more difficult to implement. The therapy is emphatic
about the importance of considering pulmonary rehabili-
tation, a therapeutic tool that although accepted by
everyone is not available to most patients who would
benefit from the modality [8]. Long term oxygen therapy
is also addressed, using a clear algorithm that has
resisted the test of time and that remains the most influ-
ential treatment in terms of survival since the initial
studies were completed.
A small section on home care introduces this concept,
the scope of which still remains a matter of debate.
Many factors play a role in the feasibility of caring for
complex patients always at home. There is no question
that it is the desired environment for all sick persons,
but social realities and societal resources end up inter-
playing in the final equations of these decision. It would
be fair to say that in this review, not every aspect is
touched in depth (this is not the scope of the work), but
at least attempts were made to cover the most important
parts in a relatively brief document. In this regard, the
authors need to be commended, because they end the
practicum with a relatively long and important review
and recommendations related to end-of-life issues and
of palliative care, which as I mentioned at the beginning
of this editorial, is a frequently absent discussion in most
documents.
I cannot end without discussing several aspects that
are absent from this document. Perhaps and most im-
portant, one that is common even to guidelines and this
is the area of the co-morbidites of COPD [9]. I shall be
the first to recognize that it is not easy to provide prac-
tical recommendations to all of the potential co-
morbidities that may affect COPD patients, but efforts
have to be made to begin to tackle this important fact.
Secondly, it is not uncommon that patients with the se-
vere disease have to face the possibility of surgery, an
event that presents a risk for some, but sometimes an
opportunity to improve life style or even survival itself.
How to address it, and the practical approach to such
events could be of use in a document such as this one.
Finally, the frequent event of exacerbations is not a com-
ponent of these recommendations, perhaps an area for a
future supplement to this well-developed document.
My compliments to the authors and to AIMAR for
having supported it. The more effort we devote to the
cause, the more likely it is that we shall be successful.
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